Cascades Capital Asset Management, LLC
Position in JNJ — Johnson & Johnson
CIK 2035512
GREENSBORO, NC
Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$878,990
+$51,317 QoQ
Shares Held
3,461
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#3,139
of 4,676 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cascades Capital Asset Management, LLC holds $6,734,291 across 6 Drug Manufacturers - General names. JNJ ranks #3 (13.1% of the industry book) .
All Filings in JNJ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $878,990 | 3,461 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $827,673 | 3,386 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $699,077 | 3,378 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $624,494 | 3,368 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $515,378 | 3,374 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $538,482 | 3,247 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $467,990 | 3,236 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $574,016 | 3,542 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||